Apeloa Pharmaceutical Co.,Ltd (SHE:000739)

Market Cap	19.60B
Revenue (ttm)	12.26B
Net Income (ttm)	1.07B
Shares Out	1.16B
EPS (ttm)	0.92
PE Ratio	18.38
Forward PE	17.41
Dividend	0.32 (1.90%)
Ex-Dividend Date	May 23, 2024

Volume	12,678,468
Average Volume	11,313,438
Open	15.37
Previous Close	16.92
Day's Range	15.37 - 17.17
52-Week Range	12.23 - 18.96
Beta	0.11
RSI	71.84
Earnings Date	Mar 11, 2025

About SHE:000739

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People’s Republic of China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 7,208
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000739

Financial Performance

In 2023, SHE:000739's revenue was 11.47 billion, an increase of 8.81% compared to the previous year's 10.54 billion. Earnings were 1.06 billion, an increase of 6.69%.